Anti-double stranded antibody: Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus

Saudi Medical Journal

Volumn 31, Issue 1, 2010, Pages 32-36

  Almogren, Adel ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; DNA;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL LABORATORY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SERODIAGNOSIS; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77949380257     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Feely RH. Systemic Lupus Erythematosus: A Review. Rheumatol Rehabil 1978; 17: 79-82.
2. Burnham TK. Antinuclear antibodies II. The prognostic significance of nuclear immunofluorescent patterns in lupus erythematosus. Arch Dermatol 1975; 11: 203-207.
3. Nakamura RM, Tan EM. Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases. Clin Lab Med 1986; 6: 41-53.
4. Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with cell nuclei and CNA in lupus erythematosus. Proc Soc Exp Biol Med 1957; 96: 575-579.
5. Miescher P, Strassle R. New serological methods for detection of LE factor. Vox Sang 1957; 2: 283-287.
6. Cepellini R, Polli E, Celeda F. A DNA reacting factor in serum of a patient with lupus erythematosus. Proc Soc Exp Biol Med 1957; 96: 572-574.
7. Monestier M, Kotzin BL. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 1992; 18: 415-436.
8. Fishbein E, Alarcon-Segovia D, Vega JM. Antibodies to histones in systemic lupus erythematosus. Clin Exp Immunol 1979; 36: 145-150.
9. Asherson GL. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol 1959; 40: 209-215.
10. Tan EM. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest 1967; 46: 735-745.
11. Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-122.
12. Scopelitis E, Biundo JJ Jr, Alspaugh MA. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 287-293.
13. Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum 1974; 17: 421-429.
14. Alspaugh MA, Talal N, Tan EM. Differentiation and characterization of autoantibodies and their antigens in Sjorgen's syndrome. Arthritis Rheum 1976; 19: 216-222.
15. Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 1977; 59: 176-178.
16. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980; 23: 617-625.
17. Feltkamp TE. Antinuclear antibody determination in a routine laboratory. Ann Rheum Dis 1996; 55: 723-727.
18. Greidinger E, Hoffman R. Antinuclear Antibody Testing: Methods, Indications, and Interpretation. Lab Medicine 2003; 34: 113-118.
19. Monestier M, Kotzin BL. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 1992; 18: 415-436.
20. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338: 1359-1368.
21. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424-432.
22. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990; 33: 634-643.
23. Esdaile JM, Abrahamowicz M, Joseph L, MacKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum 1996; 39: 370-378.
24. Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009; 4: 1.
25. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-324.
26. Ghosh P, Dwivedi S, Naik S, Agarwal V, Verma A, Aggarwal A, et al. Antinuclear antibodies by indirect immunofluorescence: optimum screening dilution for diagnosis of systemic lupus erythematosus. Indian J Med Res 2007; 126: 34-38.
27. Yang JS, Hsieh RP, Shen MC. [A comparative study of antinuclear antibody measurement using different cells as nuclear substrates]. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1991; 24: 299-310.
28. Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clin Rheumatol 2004; 23: 509-515.
29. Servais G, Karmali R, Guillaume MP, Badot V, Duchateau J, Corazza F. Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells. Clin Chem Lab Med 2009; 47: 543-549.
30. Manoussakis MN, Garalea KL, Tzioufas AG, Moutsopoulos HM. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. Clin Rheumatol 1988; 7: 465-469.
31. Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis 2004; 63: 386-394.